Quinoline-(C=O)-(multiple amino acids)-leaving group compounds for pharmaceutical compositions and reagents
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
May 2, 2002
app pub date -
May 29, 2001
filing date -
Aug 30, 2000
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
This invention concerns compounds and a pharmaceutical composition of the structure: wherein: 1 R.sup.1 is selected from the group consisting of alkyl, substituted alkyl, aryl, and substituted aryl which group will produce a natural amino acid structure or an unnatural amino acid structure, and the carbon adjacent to R.sup.1 is in the D or L configuration; R.sup.2 is selected from the group consisting of --F and 2 wherein R.sup.3 and R.sup.4 are each selected from the group consisting of hydrogen, alkyl, fluoro, chloro, carboxyl, alkoxy, alkyl carbonyl, aryl carbonyl, and amino; R.sup.5 and R.sup.5' are each independently selected from the group consisting of hydrogen, alkyl, alkoxy, fluoro, chloro, carboxy, alkoxy, alkyl carbonyl, aryl carbonyl, and amino, R.sup.6 is selected from the group consisting of alkyl having 1 to 10 carbon atoms, aryl or substituted aryl, and m is 1, 2 or 3. These compounds are reagents and pharmaceutical compositions have pro-drug and apoptosis properties and are useful in a variety of therapies, for diseases such as arthritis, ALS, MS, and the like.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully